Ask AI

Redefining the Future of PDAC: Preparing for RAS(ON)-Targeted Therapies

Enhance your understanding of the latest clinical data on RAS-targeted agents for the treatment of pancreatic cancer through a podcast, expert-authored ClinicalThought commentary, and certified text module with accompanying downloadable slides.

Share

Program Content

Activities

RAS Inhibitors for PDAC
Experts Discuss Novel RAS-Targeted Therapy for Pancreatic Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 24, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from Revolution Medicines, Inc.

Revolution Medicines, Inc.